The changing face of p53 in head and neck cancer

M Partridge1, D E Costea, X Huang

  • 1Kings College Hospital Maxillofacial Unit, Kings College London, Denmark Hill, London SE5 8RX, UK. oralsurgery@partridgekcl.co.uk <oralsurgery@partridgekcl.co.uk>

Insights

Mutations in the p53 gene and its family members are common in head and neck cancers. Targeting the p53 family offers promising new strategies for cancer diagnosis, prognosis, and treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p53 tumor suppressor protein is crucial for preventing cancer by initiating apoptosis, DNA repair, and cell-cycle arrest under cellular stress.
  • Mutations in the p53 gene are prevalent in head and neck tumors, often leading to a non-functional p53 response even in cases with wild-type p53 protein.
  • Dysfunctional p53 pathways, due to mutations in interacting genes, are frequently observed in these cancers.

Purpose of the Study:

  • To provide a comprehensive, up-to-date overview of the mechanisms by which p53 exerts its tumor-suppressive functions.
  • To summarize current knowledge regarding the p53 family members, p63 and p73.
  • To elucidate the combined role of the p53 family in influencing treatment responses.

Main Methods:

  • Review of existing scientific literature on p53 function, mutations, and related pathways in cancer.
  • Analysis of the roles of p53, p63, and p73 in cellular stress responses and tumor development.
  • Synthesis of information regarding the therapeutic implications of targeting the p53 family.

Main Results:

  • The p53 pathway is a critical determinant in preventing cancer development through various cellular mechanisms.
  • Head and neck tumors frequently exhibit p53 gene mutations or functional inactivation of the p53 pathway.
  • The p53 family, including p63 and p73, plays a significant role in treatment response.

Conclusions:

  • The p53 family represents a key area for developing novel diagnostic, prognostic, and therapeutic strategies for head and neck cancers.
  • Given the lack of other common mutations, the p53 family emerges as a primary target for future cancer research and clinical applications.
  • Understanding the intricate functions of the p53 family is essential for advancing precision medicine in oncology.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...